New Type of Stem Cells that Accelerate Discovery
Normal human cells contain two copies of each gene – one inherited from a mother, and one from a father. An international collaboration of scientists including...
Normal human cells contain two copies of each gene – one inherited from a mother, and one from a father. An international collaboration of scientists including...
NYSCF does not treat patients with stem cell therapies. Please visit www.clinicaltrials.gov for a complete listing of clinical trials being conducted worldwide, or consult your physician. Stem cell research...
NYSCF wants to transform stem cell treatments from dreams to reality. In order to move stem cell-based cures from the theoretical and into clinics, scientists must...
The Wall Street Journal profiled Susan L. Solomon, NYSCF CEO and Co-Founder. Part of the “Weekend Confidential” series, previously headlining Robert A.M. Stern, Tom Colicchio, and...
The New York Stem Cell Foundation (NYSCF) applauds the National Academies of Sciences, Engineering, and Medicine’s Institute of Medicine (IOM) report released on February 3rd, 2016...
NYSCF – Druckenmiller Fellow Larry Luchsinger, PhD, studies the energy producing centers of the cell, mitochondria, to better understand the cells that produce blood cells, hematopoietic...
NYSCF – Robertson Investigator Dr. Alexander Meissner, Broad Institute of MIT and Harvard, along with NYSCF – Robertson Investigator Dr. Gabsang Lee, John Hopkins University, explored...
NYSCF – Robertson Neuroscience Investigator Dr. Paola Arlotta, Harvard Stem Cell Institute and the Broad Institute of Harvard and MIT, showed that neuronal networks of communication...
At The 2015 NYSCF Conference: Tenth Annual Translational Stem Cell Research Conference, NYSCF announced Franziska Michor. PhD, as the 2015 recipient of the Robertson Stem Cell...
At the 10th Annual NYSCF Conference on Translational Stem Cell Research NYSCF will bring together world leaders in biotechnology, regenerative medicine, precision medicine, and pharmaceuticals to...
The National Institute of Health (NIH) invited Susan Solomon to chair and moderate a panel at September’s NIH Workshop on Reproducibility in Cell Culture Studies. The...
NYSCF announces a new partnership with Q-State Biosciences (Q-State) to generate high quality stem cells from patient blood cells. The collaboration will mark the first time...
NYSCF Vice President of Stem Cell Research, Dr. Scott Noggle leads The Stem Cell Podcast through a behind-the-scenes view of NYSCF’s one-of-a-kind robotic technology that creates...
NYSCF – Robertson Stem Cell Investigator Dr. Alex Meissner, Harvard University, published his latest work studying the development and interaction of binding factors in mouse stem...
NYSCF designed and has built a revolutionary, high-throughput robotic platform that automates and standardizes the process of transforming patient samples into stem cells. This one-of-a-kind system...
NYSCF – Robertson Stem Cell Investigator Dr. Jayaraj Rajagopal, Massachusetts General Hospital, discovered that parent stem cells can serve as niches, or cell maintenance and regulatory...
NYSCF – Robertson Stem Cell Investigator Dr. Jacob Hanna, Weizmann Institute of Science, tested an alternate method of stem cell transdifferentiation – the process of a...
NYSCF – Robertson Stem Cell Investigator Dr. Valentina Greco and NYSCF – Druckenmiller Fellow Dr. Panteleimon Rompolas and their team from Yale University discovered clues to...
NYSCF – Robertson Stem Cell Investigator and 2014 NYSCF – Robertson Stem Cell Prize Winner Dr. Marius Wernig, Stanford University School of Medicine, discovered key cell...
NYSCF – Robertson Stem Cell Investigator Dr. Alex Meissner, Harvard University, published his latest work on the role of transcription factors in stem cell differentiation in...
NYSCF – Robertson Stem Cell Investigator Dr. Jayaraj Rajagopal, Massachusetts General Hospital, published his latest research on stem cell response in injury repair in Cell Stem...
Dr. Stephen Chang, NYSCF Vice President for Research and Development, presented the NYSCF Global Stem Cell Array technology at the National Institutes of Health Fifth AIMBE Workshop...
NYSCF CEO Susan L. Solomon penned an editorial in Roll Call commending the approval of mitochondrial replacement therapy, or MRT, by the UK Parliament House of Commons...
On Tuesday, February 3rd, the UK Parliament will debate whether to approve the use of mitochondrial replacement therapy or MRT in the UK. This therapy, similar...
NYSCF – Robertson Stem Cell Investigator Dr. Paul Tesar, of Case Western Reserve University School of Medicine, is the recipient of the International Society for Stem...